Close Menu

An international team led by investigators at Emory University explore human host B cell responses over time in Ebola virus (EBOV) infection survivors. Using ELISA and viral plaque reduction assays, the researchers profiled antibodies developed against an EBOV surface glycoprotein in blood samples from four Ebola individuals who survived a West African outbreak that started in 2014.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.